Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

EGFR/Cytokine-IN-1

SKU: orb3173853

Description

EGFR/Cytokine-IN-1 is an inhibitor targeting EGFR with an IC50 of 0.03 μM, as well as cytokines TNF-α (IC50= 3.1 μM) and IL-6 (IC50= 1.6 μM). This compound demonstrates significant anticancer activity against both A549 and MCF7 cell lines. It effectively reduces IL-6 and TNF-α levels in A549 cells and exhibits favorable ADMET properties. EGFR/Cytokine-IN-1 is capable of inducing apoptosis in a dose-dependent manner and is applicable in breast and lung cancer research.

Images & Validation

Key Properties

TargetInterleukin,TNF,EGFR,Apoptosis

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

EGFR/Cytokine-IN-1 (orb3173853)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%